Fonte: Bmc cancer. Unidade: FM
Assuntos: INSTITUIÇÕES DE SAÚDE, NEOPLASIAS, QUIMIOTERAPIA, EVENTO ADVERSO A MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIRARDI, Daniel M e HOFF, Paulo Marcelo G. Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis. Bmc cancer, v. 18, 2018Tradução . . Disponível em: https://doi.org/10.1186/s12885-018-4305-x. Acesso em: 23 out. 2025.APA
Girardi, D. M., & Hoff, P. M. G. (2018). Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis. Bmc cancer, 18. doi:10.1186/s12885-018-4305-xNLM
Girardi DM, Hoff PMG. Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis [Internet]. Bmc cancer. 2018 ; 18[citado 2025 out. 23 ] Available from: https://doi.org/10.1186/s12885-018-4305-xVancouver
Girardi DM, Hoff PMG. Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis [Internet]. Bmc cancer. 2018 ; 18[citado 2025 out. 23 ] Available from: https://doi.org/10.1186/s12885-018-4305-x
